SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-022853
Filing Date
2017-04-28
Accepted
2017-04-28 08:00:45
Documents
4
Period of Report
2017-06-13
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A v464712_def14a.htm DEF 14A 269715
2 GRAPHIC pg01img1_def14a.jpg GRAPHIC 15667
3 GRAPHIC pg25img1_def14a.jpg GRAPHIC 184957
4 GRAPHIC pg26img1_def14a.jpg GRAPHIC 178713
  Complete submission text file 0001144204-17-022853.txt   793709
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36357 | Film No.: 17791711
SIC: 2834 Pharmaceutical Preparations